Veterinary Medicines

Calcitat 25, solution for infusion and injection in cattle

Authorised
  • Calcium gluconate monohydrate
  • Calcium borogluconate
  • Calcium hydroxide
  • Magnesium chloride hexahydrate
Download as PDF

Product identification

Medicine name:
Calcitat 25, solution for infusion and injection in cattle
Active substance:
  • Calcium gluconate monohydrate
  • Calcium borogluconate
  • Calcium hydroxide
  • Magnesium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    1.55
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium borogluconate
    21.45
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium hydroxide
    0.66
    gram(s)
    /
    100.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    3.25
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection/infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AA
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 1 500 ml bottle.Vial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.
  • 250 ml.Vial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.
  • 20 500 ml bottlesVial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10826/001/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download